Role of interleukin-1 and prostaglandin in in vitro bone resorption induced by Actinobacillus actinomycetemcomitans lipopolysaccharide

J Periodontal Res. 1991 May;26(3 Pt 1):155-60. doi: 10.1111/j.1600-0765.1991.tb01639.x.

Abstract

Lipopolysaccharide (Y4 LPS) isolated from Actinobacillus actinomycetemcomitans strain Y4 induced bone resorption in BALB/c mouse calvaria organ culture. The calcium release from LPS-low responsive C3H/HeJ mouse calvaria by Y4 LPS was very low. Indomethacin almost completely inhibited prostaglandin E2 (PGE2) production by Y4 LPS-stimulated BALB/c mouse calvaria, but did not suppress interleukin-1 (IL-1) release from the calvaria, and partially suppressed the bone resorption. Dexamethasone strongly inhibited the PGE2 and IL-1 production by Y4 LPS-stimulated BALB/c mouse calvaria, as well as Y4 LPS-induced bone resorption. Dexamethasone inhibited expression of membrane IL-1 on osteoblastic cells stimulated with Y4 LPS, but indomethacin did not. Furthermore, anti-IL-1 serum partially suppressed the calcium release from Y4 LPS-stimulated BALB/c mouse calvaria. These results suggest that both PGE2 and IL-1 participate in Y4 LPS-induced bone resorption in vitro.

MeSH terms

  • Actinobacillus*
  • Animals
  • Bone Resorption / microbiology
  • Bone Resorption / physiopathology*
  • Dexamethasone / pharmacology
  • Indomethacin / pharmacology
  • Interleukin-1 / antagonists & inhibitors
  • Interleukin-1 / physiology*
  • Lipopolysaccharides / metabolism*
  • Mice
  • Mice, Inbred BALB C
  • Mice, Inbred C3H
  • Prostaglandin Antagonists
  • Prostaglandins E / physiology*

Substances

  • Interleukin-1
  • Lipopolysaccharides
  • Prostaglandin Antagonists
  • Prostaglandins E
  • Dexamethasone
  • Indomethacin